Dear Editor,

COVID-19 infections may affect other noncommunicable diseases, such as stroke, both directly and indirectly. Stroke may increase the probability of severe infection and mortality in COVID-19 infections. COVID-19 may lead to cardiac injury, arrhythmia, myocarditis, coagulopathy, and consequently stroke [1]. As an example, in Iran, neurologists identified some stroke cases among COVID-19 cases.

Given the health infrastructure differences, economic differences, and previous differences in the burden of stroke between low- and middle-income (LMICs) versus high-income countries [2, 3], LMICs, in particular, may face a considerable strain with a possible negative impact on the healthcare delivery system. While we are globally fighting COVID-19, we need to implement feasible approaches to prevent or at least minimize any breakdown in the previous preventive and treatment approaches. We here recommend some suggestions and a call to action in LMICs.

Healthcare professionals are at a higher risk of COVID-19 than the normal population [4]. Given the previous staff shortages in healthcare in many LMICs, providing personal protection equipment should be prioritized. We encourage international organizations, such as the World Federation of Neurology (WFN) and World Stroke Organization (WSO), to help provide personal protection equipment for LMICs.

Social isolation does not mean lack of social interactions. We recommend health policymakers to authorize telemedicine technology in LMICs. Many important aspects of acute stroke management, from EMS dispatch to the selection of eligible cases for intravenous thrombolysis or endovascular therapy, can be performed via Telestroke [5].

Expensive telemedicine and telerehab programs are not appropriate for many LMIC situations. Low-priced, accessible, and secured cross-platform mobile applications can facilitate telemedicine/telerehab usage. Institutions may explore with the Ethics Committee and Institutional Review Board whether commercially available low-cost smartphone applications can substitute in locations where Telestroke networks are not available. Besides, the security and confidentiality of telemedicine systems should be assured and perhaps funded by social media companies.

Early supported discharge services should be organized in LMICs [6]. Stroke centers need to practice 24/7 outpatient support using secured video-audio applications or at least telephone questionnaires to address vascular risk factors and assure medication compliance. Important screening questions with simple preventive measures to reduce the chance of deep vein thrombosis, falls, urinary tract infections, and pneumonia could be sent using Bluetooth/email to patients or the next of kin instead of paper-based documents. Based on anecdotal data, some crucial investigations such as formal swallowing assessments were reduced in some centers for fear of contagion.

All unnecessary diagnostic activities should be summarized or merged for the sake of decreasing the rate of, or at least the fear of, COVID-19. If possible, it is crucial to separate CT units of COVID-19 cases from all other cases. Neurologists can send Holter monitoring to selected patients along with installation instructions or a telephone call for installation and a prepaid envelope to mail it back.

Finally, stroke centers in the world need to support each other. Worldwide prestigious neurology centers, for example, WSO or WFN, can host a network of centers to share the best policies and experiences. LMICs need to be supported to continue fighting against stroke. Neurology is a big but close-knit family.

The authors have no conflicts of interest to declare.

The authors did not receive any funding.

Study concepts, study design, manuscript preparation, definition of intellectual content, manuscript editing, and manuscript revision/review: Afshin Borhani-Haghighi, M. Reza Azarpazhooh, and Reza Bavarsad Shahripour.

1.
Madjid
M
,
Safavi-Naeini
P
,
Solomon
SD
,
Vardeny
O
.
Potential effects of coronaviruses on the cardiovascular system: a review
.
JAMA Cardiol
.
2020
.
2.
Azarpazhooh
MR
,
Etemadi
MM
,
Donnan
GA
,
Mokhber
N
,
Majdi
MR
,
Ghayour-Mobarhan
M
, et al.
Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East
.
Stroke
.
2010 Jan
;
41
(
1
):
e3
e10
.
3.
Avan
A
,
Digaleh
H
,
Di Napoli
M
,
Stranges
S
,
Behrouz
R
,
Shojaeianbabaei
G
, et al.
Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017
.
BMC Med
.
2019 Oct
;
17
(
1
):
191
.
4.
The Lancet
.
COVID-19: protecting health-care workers
.
Lancet
.
2020 Mar
;
395
(
10228
):
922
.
5.
Corley
J
.
Telestroke: India's solution to a public health-care crisis
.
Lancet Neurol
.
2018 Feb
;
17
(
2
):
115
6
.
6.
Visvanathan
V
.
Early supported discharge services for people with acute stroke: a Cochrane review summary
.
Int J Nurs Stud
.
2019 Jun
;
94
:
186
7
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.